Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Sulforaphane, a compound found in cruciferous vegetables like broccoli, has been investigated for its potential anti-inflammatory and antioxidant properties, which are relevant to autoimmune diseases such as rheumatoid arthritis (RA). Preclinical studies, primarily in cell cultures and animal models, suggest that sulforaphane can inhibit the activation of nuclear factor kappa B (NF-κB), a transcription factor involved in the inflammatory processes underlying RA. It also appears to reduce the expression of pro-inflammatory cytokines such as TNF-α and IL-1β, and can decrease oxidative stress in joint tissues. For example, a 2013 study in mice demonstrated that sulforaphane administration reduced joint inflammation and cartilage destruction in collagen-induced arthritis models, a proxy for human RA. However, human clinical trials directly evaluating sulforaphane supplementation in RA patients are lacking as of mid-2024. The bulk of evidence remains preclinical, and while mechanistic plausibility exists, there is insufficient clinical validation to recommend sulforaphane as an established treatment for RA. Therefore, its use is supported by scientific rationale and promising early-stage evidence, but not yet by robust clinical trials in humans.

More about Sulforaphane
More about Rheumatoid Arthritis

Other ingredients used for Rheumatoid Arthritis

Other health conditions supported by Sulforaphane

Products containing Sulforaphane